| Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms‐like tyrosine kinase 3‐mutated acute myeloid leukemia G Battipaglia, A Ruggeri, R Massoud, J El Cheikh, M Jestin, A Antar, ... Cancer 123 (15), 2867-2874, 2017 | 111 | 2017 |
| Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis N Gagelmann, F Passamonti, C Wolschke, R Massoud, C Niederwieser, ... Haematologica 107 (8), 1840, 2022 | 63 | 2022 |
| Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness M Boileau, M Shirinian, T Gayden, AS Harutyunyan, CCL Chen, ... Nature communications 10 (1), 2891, 2019 | 52 | 2019 |
| Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 mutated acute myeloid … G Battipaglia, R Massoud, SO Ahmed, O Legrand, J El Cheikh, R Youniss, ... Clinical Lymphoma Myeloma and Leukemia 19 (8), 506-508, 2019 | 46 | 2019 |
| Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma J El Cheikh, R Massoud, I Abudalle, B Haffar, R Mahfouz, ... Bone marrow transplantation 52 (7), 1074-1077, 2017 | 43 | 2017 |
| Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT J El-Cheikh, R Massoud, E Fares, N Kreidieh, R Mahfouz, ... Bone marrow transplantation 52 (6), 918-921, 2017 | 41 | 2017 |
| Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic … R Massoud, N Gagelmann, U Fritzsche-Friedland, G Zeck, S Heidenreich, ... haematologica 107 (4), 857, 2022 | 40 | 2022 |
| Impact of adding antithymocyte globulin to posttransplantation cyclophosphamide in haploidentical stem-cell transplantation J El-Cheikh, R Devillier, R Dulery, R Massoud, F Al Chami, N Ghaoui, ... Clinical Lymphoma Myeloma and Leukemia 20 (9), 617-623, 2020 | 25 | 2020 |
| Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis J El-Cheikh, I El Dika, R Massoud, M Charafeddine, R Mahfouz, ... Clinical Lymphoma Myeloma and Leukemia 17 (3), 179-185, 2017 | 23 | 2017 |
| Feasibility of the combination of venetoclax and asparaginase-based chemotherapy for adult patients with relapsed/refractory acute lymphoblastic leukemia J El-Cheikh, NM Moukalled, H El Darsa, R Massoud, SS Kanj, R Mahfouz, ... Clinical Lymphoma Myeloma and Leukemia 18 (10), e441-e444, 2018 | 20 | 2018 |
| Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation R Massoud, R Assi, E Fares, B Haffar, M Charafeddine, N Kreidieh, ... Journal of Clinical Virology 95, 36-41, 2017 | 19 | 2017 |
| Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation NM Moukalled, H El Darsa, Y Haibe, R Massoud, SS Kanj, R Mahfouz, ... Bone marrow transplantation 54 (4), 620-624, 2019 | 16 | 2019 |
| Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive … E Klyuchnikov, A Badbaran, R Massoud, U Fritsche-Friedland, D Janson, ... Transplantation and Cellular Therapy 27 (10), 841-850, 2021 | 14 | 2021 |
| Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection M Christopeit, M Reichard, C Niederwieser, R Massoud, E Klyuchnikov, ... Bone Marrow Transplantation 56 (6), 1478-1481, 2021 | 14 | 2021 |
| A Pin1/PML/P53 axis activated by retinoic acid in NPM-1c acute myeloid leukemia R Hleihel, H El Hajj, HC Wu, C Berthier, HH Zhu, R Massoud, ... haematologica 106 (12), 3090, 2021 | 12 | 2021 |
| Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience F Daniel, L Hassoun, M Husni, A Sharara, A Soweid, K Barada, B Haffar, ... Current research in translational medicine 67 (1), 16-19, 2019 | 11 | 2019 |
| Trends in Hematopoietic Stem Cell Transplant Activity in Lebanon A Bazarbachi, A Zahreddine, R Massoud, J Cheikh, C Hanna, F Nasr, ... Hematology/Oncology and Stem Cell Therapy, 2017 | 10 | 2017 |
| Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma J Kort, A Chidiac, R El Sayed, R Massoud, R Nehme, A Bazarbachi, ... Leukemia & lymphoma 61 (7), 1732-1735, 2020 | 8 | 2020 |
| Post-Transplantation Day+ 100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk … E Klyuchnikov, A Badbaran, R Massoud, U Fritzsche-Friedland, ... Transplantation and Cellular Therapy 28 (7), 374. e1-374. e9, 2022 | 7 | 2022 |
| Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant R Salem, R Massoud, B Haffar, R Mahfouz, A Bazarbachi, J El-Cheikh Bone marrow transplantation 52 (8), 1187-1190, 2017 | 6 | 2017 |
